Both in Pharmaceuticals
Mineralys Therapeutics vs Rapport Therapeutics
Over the past year MLYS returned −60.3% and RAPP returned −6.7%; their daily moves had a correlation of 0.27.
MLYS −60.3% RAPP −6.7%Growth of $1, one year, split-adjusted
| Metric | MLYS | RAPP |
|---|---|---|
| Price | $15.55 | $25.13 |
| Market cap | $1.37B | $1.42B |
| Today | −14.47% | +0.32% |
| 1 month | −34.2% | −21.9% |
| 6 months | −47.6% | −29.3% |
| Year to date | −57.2% | −17.2% |
| 1 year | −62.2% | −6.5% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | 70.8× |
| Net cash | $563.8M | $436.1M |
| Dividend yield | — | — |
| Volatility (60d) | 72.0% | 79.9% |
| Short % of float | 11.6% | 10.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).